关注
Elizabeth Kutter
Elizabeth Kutter
Professor Emeritas, Evergreen State College
在 evergreen.edu 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Tackling antibiotic resistance
K Bush, P Courvalin, G Dantas, J Davies, B Eisenstein, P Huovinen, ...
Nature Reviews Microbiology 9 (12), 894, 2011
12402011
Phage treatment of human infections
ST Abedon, SJ Kuhl, BG Blasdel, EM Kutter
Bacteriophage 1 (2), 66-85, 2011
11272011
Bacteriophage T4 genome
ES Miller, E Kutter, G Mosig, F Arisaka, T Kunisawa, W Rüger
Microbiology and molecular biology reviews 67 (1), 86-156, 2003
8972003
Bacteriophages: biology and applications
E Kutter, A Sulakvelidze
CRC Press, 2004
8662004
Phage therapy in clinical practice: treatment of human infections
E Kutter, D De Vos, G Gvasalia, Z Alavidze, L Gogokhia, S Kuhl, ...
Current pharmaceutical biotechnology 11 (1), 69-86, 2010
8412010
Phage host range and efficiency of plating
E Kutter
Bacteriophages, 141-149, 2009
4942009
A Restriction Map of the Bacteriophage T4 Genome
H O’Farrell Patrick, K Elizabeth, N Mikiye
Mol Gen Genet 179 (2), 421-435, 2010
368*2010
A restriction map of the bacteriophage T4 genome
PH O'Farrell, E Kutter, M Nakanishi
Molecular and General Genetics MGG 179 (2), 421-435, 1980
3681980
In vitro and in vivo bacteriolytic activities of Escherichia coli phages: implications for phage therapy
S Chibani-Chennoufi, J Sidoti, A Bruttin, E Kutter, S Sarker, H Brüssow
Antimicrobial agents and chemotherapy 48 (7), 2558-2569, 2004
3532004
Bacteriophage therapy in humans
E Kutter
Bacteriophages, Biology and Applications, 381-436, 2005
315*2005
Basic phage biology
B Guttman, R Raya, E Kutter
Bacteriophages: Biology and applications 4, 2005
3062005
14 Bacteriophage Therapy in Humans
A Sulakvelidze, E Kutter
Bacteriophages: biology and applications, 381, 2004
3022004
Quality and safety requirements for sustainable phage therapy products
JP Pirnay, BG Blasdel, L Bretaudeau, A Buckling, N Chanishvili, JR Clark, ...
Pharmaceutical research 32 (7), 2173-2179, 2015
2442015
Bacteriophage treatment of intransigent diabetic toe ulcers: a case series
R Fish, E Kutter, G Wheat, B Blasdel, M Kutateladze, S Kuhl
Journal of wound care 25 (Sup7), S27-S33, 2016
2142016
Isolation and characterization of a new T-even bacteriophage, CEV1, and determination of its potential to reduce Escherichia coli O157: H7 levels in sheep
RR Raya, P Varey, RA Oot, MR Dyen, TR Callaway, TS Edrington, ...
Applied and environmental microbiology 72 (9), 6405-6410, 2006
2132006
Bacteriophage Isolated from Feedlot Cattle Can Reduce Escherichia coli O157:H7 Populations in Ruminant Gastrointestinal Tracts
TR Callaway, TS Edrington, AD Brabban, RC Anderson, ML Rossman, ...
Foodborne Pathogens and Disease 5 (2), 183-191, 2008
1832008
Degradation of cytosine-containing bacterial and bacteriophage DNA after infection of Escherichia coli B with bacteriophage T4D wild type and with mutants defective in genes 46 …
EM Kutter, JS Wiberg
Journal of molecular biology 38 (3), 395-411, 1968
1801968
Evaluation of lytic activity of staphylococcal bacteriophage Sb‐1 against freshly isolated clinical pathogens
L Kvachadze, N Balarjishvili, T Meskhi, E Tevdoradze, N Skhirtladze, ...
Microbial biotechnology 4 (5), 643-650, 2011
1672011
Bacteriophage T4 infection of stationary phase E. coli: life after log from a phage perspective
D Bryan, A El-Shibiny, Z Hobbs, J Porter, EM Kutter
Frontiers in microbiology 7, 1391, 2016
1662016
Re-establishing a place for phage therapy in western medicine
EM Kutter, SJ Kuhl, ST Abedon
Future microbiology 10 (5), 685-688, 2015
1382015
系统目前无法执行此操作,请稍后再试。
文章 1–20